
PEHA
Detail Analisis & Profil Saham
Deep AI Analysis
Login untuk Analisis AIAI sedang menyusun analisis mendalam untuk PEHA...
AI Trading Signal
Volume naik 200%, RSI 70, MACD Bullish Momentum, dan PBV 0.61.
Tentang Perusahaan
PT Phapros Tbk, together with its subsidiaries, operates in the pharmaceutical industry in Indonesia. The company operates through Ethical; Over the Counter (OTC) Drugs; Generic Drugs Bearing (OCB); and Toll-in segments. It offers OTC drugs, including Antimo Anak, Antimo tablet, Livron B Plex, Becefort Sirop and tablet, Noza, Febrinex, Betafort suspensi, and Hemorogard. The company also provides ethical generic and branded products; and medical devices, as well as toll manufacturing. It also exports its products. The company was founded in 1954 and is headquartered in Jakarta Selatan, Indonesia. PT Phapros Tbk is a subsidiary of PT Kimia Farma Tbk.
Jajaran Direksi
Struktur Kepemilikan
Valuasi Utama
Data Keuangan & Metrik
Indikator Momentum
Volume & Tren MA
Berita Terkini
Phapros Tbk PT (PEHA)
ASII Mau Tambah Saham AUTO, Sementara PEHA Raup Laba Rp 14,97 Miliar
Raup Laba Rp 27 M, PEHA Tebar Dividen 15%
2 tahun absen, saham farmasi PEHA siap bagikan dividen, cek rinciannya!
Phapros (PEHA) membidik penjualan obat tumbuh 18-27 persen pada 2025
Phapros (PEHA) Tebar Dividen Rp6,64 Miliar
Emiten Farmasi
Pengamat: Jangka panjang, saham Phapros layak dikoleksi
Tidak ada berita Nasional terbaru.
Tidak ada berita Global terbaru.